Quick Answer
Minerva Neurosciences, Inc. reported Operating Income of -$15.10 million for fiscal year 2025.
Minerva Neurosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$15.10M | +30.9% |
| 2024 | -$21.85M | +5.5% |
| 2023 | -$23.12M | +8.4% |
| 2022 | -$25.23M | +44.4% |
| 2021 | -$45.37M | -2556.5% |
| 2020 | $1.85M | +102.4% |
| 2019 | -$75.87M | -46.7% |
| 2018 | -$51.73M | -25.6% |
| 2017 | -$41.17M | -36.4% |
| 2016 | -$30.19M | -15.6% |
| 2015 | -$26.11M | +52.4% |
| 2014 | -$54.87M | -1628.2% |
| 2013 | -$3.17M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.84M | +34.9% | +15.7% |
| June 30, 2025 | -$3.37M | +46.3% | +13.5% |
| March 31, 2025 | -$3.90M | +41.6% | +10.6% |
| September 30, 2024 | -$4.37M | +28.2% | +30.4% |
| June 30, 2024 | -$6.28M | -38.9% | +6.1% |
| March 31, 2024 | -$6.68M | -24.9% | -9.9% |
| September 30, 2023 | -$6.08M | -16.7% | -34.5% |
| June 30, 2023 | -$4.52M | +35.1% | +15.5% |
- Minerva Neurosciences, Inc. showed an increase of +30.9% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, Minerva Neurosciences, Inc.’s operating income has declined by 375.7% (from -$3.17 million to -$15.10 million).
- The most recent figure is from Minerva Neurosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: